HOME / Notice / News / EN
1. Brief introduction of your company and current status please. Hello. This is Shin, Dong-Hwa, the CEO and Chairman of NKCL Bio Group Inc. NKCL Bio Group Inc.(NKCL Bio Group) is a bio-specialized company that researches and develops NK cell culture technology based on its cell culture technology. NK...
NKCL Bio Group Inc., a company specialized in NK cell culture technology, participated in the 1st International Virus and Bacteria Industry Expo (ViBac 2022) and unveiled a new concept of skin anti-aging solution using NK cells, which has attracted attention. This expo was hosted by Makers Union and ...
The 2022 Virus and Bacteria Trend Conference will be held, where domestic bacteria and virus-related companies come together to share the latest information and future strategies in the field. NKCL Bio Group Inc.(NKCL) has announced that it will participate in the '2022 International Virus and Bacter...
NKCL Bio Group Inc. (NKCL) has announced that it had signed a 3-party MOU with PnB Group and MK Lab for distribution in the Philippines. PnB Group is a blockchain-based IT company, leading the Philippine market in fintech and IT solutions, and MK Lab is a company that operates K-beauty business in th...
On July 4, NKCL Bio Group Inc. (CEO Shin, Donghwa) and I Partners Group (CEO Jung, Yiho) announced that they had signed an MOU for innovative technology in the medical field. I Partners Group is a specialized company that supplies programs that combine in various areas; such as, medical device, healt...
